Literature DB >> 1629710

Receptor for pre-S1(21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction.

S Dash1, K V Rao, S K Panda.   

Abstract

Attachment of hepatitis B virus to a hepatoblastoma cell line (HepG2) was examined using a synthetic peptide corresponding to the pre-S1 (21-47) region of the envelope protein. Scatchard analysis revealed a single class binding site of Kd 104 +/- 27 nM/l and 5.4 +/- 1.2 x 10(5) sites per cell. Competition of HBV with pre-S1 peptides was dose dependent, and demonstrated it as the dominant binding site. In view of the suggested sequence homology between the peptide and IgA, cross-competition studies were carried out. The results indicate no direct role of IgA receptor in HBV binding. The receptor for the pre-S1 peptide was identified as a single major peptide of molecular weight 31 kD using in-situ ligand receptor crosslinking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629710     DOI: 10.1002/jmv.1890370208

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus.

Authors:  C J Ryu; D Y Cho; P Gripon; H S Kim; C Guguen-Guillouzo; H J Hong
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 3.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 4.  Molecular biology of the hepatitis B virus for clinicians.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2012-10-18

5.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 6.  Deciphering the mystery of hepatitis B virus receptors: A historical perspective.

Authors:  Zaira Rehman; Ammad Fahim; Hajra Sadia
Journal:  Virusdisease       Date:  2015-07-03

Review 7.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 8.  Importance of endocytic pathways in liver function and disease.

Authors:  Barbara Schroeder; Mark A McNiven
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 9.  Clinical impact of hepatitis B and C virus envelope glycoproteins.

Authors:  Hélène Jeulin; Aurélie Velay; John Murray; Evelyne Schvoerer
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

10.  Spontaneous development of anti-hepatitis B virus envelope (anti-idiotypic) antibodies in animals immunized with human liver endonexin II or with the F(ab')2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor-ligand-like relationship between small hepatitis B surface antigen and endonexin II.

Authors:  K Hertogs; E Depla; T Crabbé; W De Bruin; W Leenders; H Moshage; S H Yap
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.